Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes During Invasive Procedures

Sponsor
National Defense Medical Center, Taiwan (Other)
Overall Status
Completed
CT.gov ID
NCT03010891
Collaborator
Ministry of Science and Technology, Taiwan (Other)
66
2
26

Study Details

Study Description

Brief Summary

The proposed 2-year study has two specific aims: (1) to examine the effects of a "bundle" of supportive interventions on preterm infants' stress (salivary cortisol and dehydroepiandrosterone [DHEA] levels and physiological signals of infant distress), sleep, and physical activity in the NICU, and (2) to explore the relationships among preterm infants' salivary cortisol and DHEA levels, physiological signals of infant distress, sleep, and physical activity. This randomized controlled trial will adopt a longitudinal repeated-measures design to examine the effects of bundled supportive interventions on preterm infants' stress (salivary cortisol and DHEA levels [using ELISA kit] and physiological signals of infant distress [using bedside electrocardiographic monitors]), sleep and physical activity (using ankle actigraphy) during their NICU hospitalization. Preterm infants (N=120) meeting the study criteria will be randomly assigned to one of two conditions: (1) control condition: usual NICU care + positioning + gentle touch +routine kangaroo mother care (KMC) < 20 minutes; (2) experimental condition: the bundle of supportive interventions (usual NICU care +positioning + gentle touch + modulating infant states + facilitated tucking + non-nutritive sucking + oral sucrose+ routine KMC > 45 minutes. Outcome variables will include infants' biological responses to stress (salivary cortisol, salivary DHEA, and physiological signals of infant distress), sleep patterns, and physical activity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: The bundle of supportive interventions
  • Behavioral: Usual NICU care
N/A

Detailed Description

Background and purpose: Preterm infants need to receive intensive care in a neonatal intensive care unit (NICU) to survive, but this care exposes them to painful procedures and a stressful environment. Repeated, painful/stressful stimuli can disturb infants' sleep, change their physiological indicators, and affect their developing brain and organs, possibly resulting in negative, long-lasting developmental consequences. Therefore, NICU clinicians caring for these vulnerable infants have two important goals: to provide early interventions to minimize preterm infants' stress/pain and to improve their sleep and physical activity. The proposed 2-year study has two specific aims: (1) to examine the effects of a "bundle" of supportive interventions on preterm infants' stress (salivary cortisol and dehydroepiandrosterone [DHEA] levels and physiological signals of infant distress), sleep, and physical activity in the NICU, and (2) to explore the relationships among preterm infants' salivary cortisol and DHEA levels, physiological signals of infant distress, sleep, and physical activity.

Methods: This randomized controlled trial will adopt a longitudinal repeated-measures design to examine the effects of bundled supportive interventions on preterm infants' stress (salivary cortisol and DHEA levels [using ELISA kit] and physiological signals of infant distress [using bedside electrocardiographic monitors]), sleep and physical activity (using ankle actigraphy) during their NICU hospitalization. Preterm infants (N=120) meeting the study criteria will be randomly assigned to one of two conditions: (1) control condition: usual NICU care + positioning + gentle touch +routine kangaroo mother care (KMC) < 20 minutes; (2) experimental condition: the bundle of supportive interventions (usual NICU care +positioning + gentle touch + modulating infant states + facilitated tucking + non-nutritive sucking + oral sucrose+ routine KMC > 45 minutes. Outcome variables will include infants' biological responses to stress (salivary cortisol, salivary DHEA, and physiological signals of infant distress), sleep patterns, and physical activity.

Expected outcomes: The study will fill a gap in knowledge about the effects of bundled supportive interventions on preterm infants' stress reactivity, sleep, and physical activity during hospitalization. This unique combination of physiological measurements of preterm infants' stress parameters and longitudinal design will provide results for establishing evidence-based clinical guidelines to provide atraumatic care to this population during intrusive procedures. Investigators also expect that bundling supportive interventions will minimize preterm infants' pain/stress as well as improve their sleep and physical activity. In the long term, the study results may help reduce the morbidity and complications due to preterm birth, save medical costs in neonatal care, and promote these infants' health and future developmental outcomes.

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Health Services Research
Official Title:
Effects of Bundled Supportive Interventions on Preterm Infants' Stress-Related Outcomes
Study Start Date :
Mar 1, 2016
Actual Primary Completion Date :
Aug 1, 2017
Actual Study Completion Date :
May 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: control condition

Preterm infants in the control condition will receive only usual NICU care, plus positioning and gentle touch during intrusive procedures.

Behavioral: Usual NICU care
usual NICU care + positioning + gentle touch +routine KMC < 20 minutes

Experimental: experimental condition

The bundle of supportive interventions will be designed to alleviate preterm infants' stress/pain from birth to discharge from the hospital NICU.

Behavioral: The bundle of supportive interventions
usual NICU care +positioning + gentle touch + modulating infant states + facilitated tucking + NNS+ oral sucrose+ routine KMC > 45 minutes

Outcome Measures

Primary Outcome Measures

  1. Preterm infant salivary cortisol [up to 3 months]

    Accessed by salivary cortisol ELISA kit

Secondary Outcome Measures

  1. Preterm infant sleep [up to 3 months]

    Accessed by Actigraphy

  2. Preterm infant physiological signals of infant distress [up to 3 months]

    Accessed by bedside electrocardiographic monitor

  3. All preterm infants' physical activity are accessed by using Actigraphy [up to 3 months]

    Accessed by Actigraphy

  4. Preterm infant salivary DHEA levels [up to 3 months]

    Accessed by salivary DHEA ELISA kit

Eligibility Criteria

Criteria

Ages Eligible for Study:
28 Weeks to 37 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (1) gestational age (GA) > 28 weeks and < 37 weeks

  • (2) birth weight < 2100g

  • (3) stable condition (score < 22 on the Neonatal Therapeutic Intervention Scoring System [NTISS] for disease severity)

  • (4) parents can speak, read and write Chinese

  • (5) parents have no history of drug/alcohol abuse

  • (6) parents agree to participate

Exclusion Criteria:
  • (1) congenital anomalies

  • (2) neurologic impairment including convulsion, intraventricular hemorrhage > grade II or periventricular leukomalacia

  • (3) documented congenital or nosocomial (infection acquired at hospital after birth) sepsis

  • (4) surgery

  • (5) severe medical conditions requiring treatments such as cortisol supplementation, sedatives, muscle relaxants, antiepileptic, or analgesic drugs

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • National Defense Medical Center, Taiwan
  • Ministry of Science and Technology, Taiwan

Investigators

  • Study Chair: Jen-Jiuan Liaw, Professor, Professor, School of Nursing, 1National Defense Medical Center, Taipei, Taiwan, ROC.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hsiang-Yun Lan, Investigator, National Defense Medical Center, Taiwan, National Defense Medical Center, Taiwan
ClinicalTrials.gov Identifier:
NCT03010891
Other Study ID Numbers:
  • 2-104-05-157
First Posted:
Jan 5, 2017
Last Update Posted:
Nov 3, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Hsiang-Yun Lan, Investigator, National Defense Medical Center, Taiwan, National Defense Medical Center, Taiwan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 3, 2020